Christian Lang

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer.

Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer.

Journal: Cancer letters

Published: November 11, 2025

Update: Organ Donation and Preservation

Update: Organ Donation and Preservation

Journal: Zentralblatt fur Chirurgie

Published: October 29, 2025

Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments.

Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments.

Journal: Cancer research

Published: July 29, 2025

Spatial imaging features derived from SUVmax location in resectable NSCLC are associated with tumor aggressiveness.

Spatial imaging features derived from SUVmax location in resectable NSCLC are associated with tumor aggressiveness.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 28, 2025

Using 18F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer.

Using 18F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 05, 2025

The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma.

The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma.

Journal: Cancers

Published: March 31, 2025

Comparative profiling of surgically resected primary tumors and their lymph node metastases in small-cell lung cancer.

Comparative profiling of surgically resected primary tumors and their lymph node metastases in small-cell lung cancer.

Journal: ESMO open

Published: August 06, 2024

Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation.

Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation.

Journal: Cancer & metabolism

Published: July 22, 2024

Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms.

Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms.

Journal: Cancer immunology, immunotherapy : CII

Published: November 06, 2023

Potential subtype-specific therapeutic approaches in small cell lung cancer.

Potential subtype-specific therapeutic approaches in small cell lung cancer.

Journal: Current opinion in oncology

Published: October 22, 2023

Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer.

Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer.

Journal: Molecular cancer

Published: September 11, 2023

C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer.

C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer.

Journal: World journal of surgical oncology

Published: August 30, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026